Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2006
12/27/2006CN1883673A Compound preparation of pseudostellaria root and preparation method thereof
12/27/2006CN1883672A Externally applied Chinese medicine for treating ulcerative stomatitis
12/27/2006CN1883670A Liver-benefiting blood circulation-activating eyesight-improving tablet
12/27/2006CN1883669A Liver-benefiting blood circulation-activating eyesight-improving capsule
12/27/2006CN1883650A Health-caring essence and preparation method thereof
12/27/2006CN1883641A Anti-ageing body-strengthening medicine for treating spleen-kidney yang deficiency and preparation method thereof
12/27/2006CN1883637A Middle jiao-warming pain-relieving preparatrion and novel preparation method
12/27/2006CN1883634A Preparation process of stomach-caring Chinese medicine with monkey head mushroom
12/27/2006CN1883616A Liver protective capsule with rhubarb and Chinese wolfberry
12/27/2006CN1883613A A health wine and processing method therefor
12/27/2006CN1883612A Kidney-replenishing sperm-supplementing granule
12/27/2006CN1883609A Chinese medicinal microsphere containing peach kernel for injection and method for preparing same
12/27/2006CN1883604A Quality control method of compound preparation with red sage root and cape jasmine for treating acute and chronic hepatitis
12/27/2006CN1883603A Compound Chinese medicinal preparation for treating toothache and method for preparing same
12/27/2006CN1883601A Chinese medicinal capsule for treating inflammation and method for preparing same
12/27/2006CN1883598A Chinese medicinal bag for treating hernia
12/27/2006CN1883594A Enema mixture for treating ileus and method for preparing same
12/27/2006CN1883590A Method for preparing ganoderma spore oil
12/27/2006CN1883582A Pharmaceutical composition for treating liver disease and method for preparing same
12/27/2006CN1883579A Method for treating jaundice hepatitis
12/27/2006CN1883569A Chinese medicinal health product
12/27/2006CN1883563A Toxin-discharging nourishing capsule
12/27/2006CN1883560A A compound Chinese medicinal preparation containing Chinese globeflower and method for preparing same
12/27/2006CN1883556A A nano preparation of 'Kang'ai' injection and method for preparing same
12/27/2006CN1883544A Chinese medicinal preparation for treating ulcerative stomatitis and method for preparing same
12/27/2006CN1883527A A health product of lucid ganoderma and preparation method thereof
12/27/2006CN1883526A Chinese medicinal soft capsule for treating hepatitis and preparation method thereof
12/27/2006CN1883520A Hypericum perforatum L. phenolic acid and injection thereof preparation method
12/27/2006CN1883511A Inclusion compound of ants supercritical extracts and preparation process thereof
12/27/2006CN1883503A Pharmaceutical composition containing anti-ulcerative drug and mucosa-protecting agent for treating gastrosis
12/27/2006CN1883501A Application of low molecular citrus pectin in regulation of blood sugar, blood fat and improvement of fatty liver
12/27/2006CN1883499A Drip pills of mangiferin and preparation method thereof
12/27/2006CN1883488A Preparation method of minocycline hydrochloride chitosan microsphere and application thereof
12/27/2006CN1883471A A nano sodium cantharidin injection and preparation method thereof
12/27/2006CN1883461A Sustained-releasing oral mucosa medicinal film
12/27/2006CN1883460A An enteric coated mini-pill of pantoprazole sodium
12/27/2006CN1883459A Enteric coated preparation of entecavir and preparation method thereof
12/27/2006CN1883458A Enteric coated preparation of lansoprazole sodium and preparation method thereof
12/27/2006CN1883443A A health buccal spray and method for preparing same
12/27/2006CN1883442A A tooth decay-resistant spray and method for preparing same
12/27/2006CN1291988C Triazaspiro [5,5] undecane derivatrives and drugs containing the same as active ingredient
12/27/2006CN1291986C Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions
12/27/2006CN1291985C Neurotrophin production/secretion promoting agent
12/27/2006CN1291984C 2-thio-substituted imidazole derivatives and use therof in pharmaceutical industry
12/27/2006CN1291757C Remedy for inflammatory bowel diseases
12/27/2006CN1291753C Antiemetic and its preparation method
12/27/2006CN1291749C Medication for treating gastric disease
12/27/2006CN1291741C Capsule of Chinese traditional medicine for treating stomach trouble
12/27/2006CN1291737C Chinese medicine composition for treating icterus hepatitis
12/27/2006CN1291734C Quality control method of Chinese medicinal soft capsule
12/27/2006CN1291729C Antiviral Chinese medicine preparation of Hypericum perforatumand its preparation process
12/27/2006CN1291711C Industrial producing process for breath refreshing tablet
12/27/2006CN1291663C Black nightshade health product and its preparation method and uses
12/26/2006US7154001 Formate salt of O-desmethyl-venlafaxine
12/26/2006US7153963 Phenylalanine derivatives
12/26/2006US7153959 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis
12/26/2006US7153958 Farnesyl transferase inhibiting benzoheterocyclic derivatives
12/26/2006US7153887 Treatment anti-neutrophil cytoplasmic antibodies-associated vasculitis in a patient resistant to corticosteroid treatment by administering gusperimus or its salt in cycles
12/26/2006US7153886 Method for treatment of peripheral inflammation of a loop ileal artificial anus
12/26/2006US7153873 E.g., 7-acetyl-5-tert-butylamino-6-phenyl-imidazo[2,1-b]-thiazol-7-ium chloride; treatment of pain, diarrhea, urinary incontinence, depression, and anxiety
12/26/2006US7153859 For prophylaxis and therapy of asthma, chronic obstructive pulmonary disease, chronic bronchitis, atopic dermatitis, urticaria, allergic rhinitis, allergic conjunctivitis, vernal conjunctivitis, eosinophilia, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis, Crohn's disease
12/26/2006US7153856 Orally administering N-(2-chloro-6-methylphenyl)-2-[4-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-6-ylamino]thiazole-5-carboxamide for treating cancer
12/26/2006US7153852 Skin disorders; antiinflammatory agents; brain disorders; chronic obstructive pulmonary disease; antiarthritic agents; inflammatory bowel disorders
12/26/2006US7153833 Therapeutic uses of SMR1 peptides
12/26/2006US7153678 Polynucleotides encoding the novel human phosphatase, RET31, and variants thereof
12/26/2006US7153669 Nucleotide sequences coding protein for use in the diagnosis, treatment and prevention of autoimmune, cell proliferative and inflammatory diseases
12/26/2006US7153526 Diagnosing bacteria infections; administering aqueou solution of silver colloids
12/26/2006US7153507 A human monoclonal antibody specifically binds to human IL-15 and to inhibit IL-15-induced proinflammatory effects; tumor necrosis factor; antiinflammatory, -arthritic, -carcinogenic, proliferative agents; rheumatic diseases; transplants
12/26/2006US7153502 Food or drink product with a disinfection property of Helicobacter pylori
12/21/2006WO2006135915A2 Methods and compositions for treating degenerative bone disorders
12/21/2006WO2006135084A1 Prophylactic or therapeutic agent for steatohepatitis or fatty liver
12/21/2006WO2006134963A1 Agent for fibrous disease comprising oxaluric acid derivtive
12/21/2006WO2006134955A1 1, 2-di(cyclic group)substituted benzene derivative
12/21/2006WO2006134877A1 Injection
12/21/2006WO2006134492A2 Acarbose methods and formulations for treating chronic constipation
12/21/2006WO2006134460A1 Chromane substituted benzimidazole derivatives as acid pump antagonists
12/21/2006WO2006134112A1 Spiro-imidaznaphthyridine derivatives as gastric acid secretion inhibitors
12/21/2006WO2006134111A1 Spiro-benzimidazoles as inhibitors of gastric acid secretion
12/21/2006WO2006133941A2 Cannabinoid active pharmaceutical ingredient for improved dosage forms
12/21/2006WO2006108686A3 Bnp agonists
12/21/2006WO2006058303A3 Modulators of muscarinic receptors
12/21/2006WO2006056888A3 Glycine as a diet supplement for the treatment of health problems that result from underlying metabolic disorders
12/21/2006US20060287389 Phenethanolamine derivatives for treatment of respiratory diseases
12/21/2006US20060287380 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide
12/21/2006US20060287372 Pharmaceutical preparations containing thiazolidinediones showing new therapeutic indications
12/21/2006US20060287340 e.g. 5-(4-fluorophenyl)-N-[2-(1-methyl-2-oxo-1,7-diazaspiro[4,4]nonan-7-yl)-6-quinolinyl]-2-pyrimidinecarboxamide; melanin concentrating hormone receptor antagonist; central nervous system disorders, cardiovascular disorders and metabolic disorders
12/21/2006US20060287338 Metalloproteinase inhibitor compounds
12/21/2006US20060287293 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction
12/21/2006US20060287286 Prophylaxis of respiratory disorders and therapy, also metod of synthesis and composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent
12/21/2006US20060287223 Remodeling and glycoconjugation of peptides
12/21/2006US20060286150 Prevent menopause syndrome; therapy for skin aging; topical applying
12/21/2006US20060286125 Immunomodulation; Yatapoxvirus polypeptide; multiple sclerosis, psoriasis, atopic dermatitis, type 1 insulin-dependent diabetes mellitus, dermatitis, Sjoigren's syndrome, encephalitis, Reiter's syndrome, psoriatic arthritis, progressive systemic sclerosis, primary biliary cirrhosis
12/21/2006US20060286109 Compositions and vaccines containing antigen(s) of Cryptosporidium parvum and of another pathogen
12/21/2006CA2627589A1 Spiro-benzimidazoles as inhibitors of gastric acid secretion
12/21/2006CA2612061A1 Stable cannabinoid compositions comprising crystalline trans-(±)-delta9-tetrahydrocannibinol
12/21/2006CA2611917A1 Injection
12/21/2006CA2610920A1 Spiro-imidaznaphthyridine derivatives as gastric acid secretion inhibitors
12/21/2006CA2610159A1 Methods to reduce oxalate concentration by administration of oxalate oxidase crystals
12/21/2006CA2608582A1 Chromane substituted benzimidazole derivatives as acid pump antagonists
12/21/2006CA2607054A1 1, 2-di(cyclic group)substituted benzene derivative